Insulin treats hyperkalemia by activating pumps on cell surfaces that pull potassium out of the bloodstream and into cells, particularly muscle cells. A standard intravenous dose lowers serum potassium by about 0.6 to 1.2 mEq/L within 15 to 20 minutes, making it one of the fastest and most reliable options for dangerously high potassium levels. It doesn’t remove potassium from the body. Instead, it temporarily redistributes it to a safer location while other treatments or the kidneys work to eliminate the excess.
How Insulin Moves Potassium Into Cells
Every cell in your body has sodium-potassium pumps embedded in its outer membrane. These pumps use energy to push three sodium ions out of the cell while pulling two potassium ions in. Under normal conditions, these pumps run at a baseline rate. Insulin dramatically increases their activity, especially in skeletal muscle, which makes up roughly 40% of body weight and acts as a massive potassium reservoir.
Insulin does this through two mechanisms working together. First, it triggers a signaling chain inside the cell that causes extra sodium-potassium pumps to be shuttled from storage compartments to the cell surface. Think of it like a restaurant opening additional checkout lanes during a rush. Within about five minutes of insulin exposure, cells begin inserting more pumps into their membranes. Second, insulin increases the activity of pumps already at the surface. The combined effect is a rapid, significant increase in the rate at which cells absorb potassium from the surrounding fluid.
This is the same signaling pathway insulin uses to help cells absorb glucose, which is why the two effects happen simultaneously and why glucose must be given alongside insulin to prevent dangerously low blood sugar.
What Happens During Treatment
The standard approach is 10 units of regular insulin given intravenously along with 25 grams of dextrose (glucose). The potassium-lowering effect begins within 10 to 20 minutes and lasts about 4 to 6 hours. In practice, doses range from 5 to 10 units of insulin and 25 to 60 grams of glucose, depending on the clinical setting and the patient’s kidney function.
Some hospitals use a weight-based approach of 0.1 units per kilogram of body weight rather than a flat 10-unit dose. This can help reduce the risk of side effects in smaller patients or those with kidney disease. Regardless of the exact dose, the expected result is a potassium drop of about 1 mEq/L, which is often enough to move a patient out of the danger zone where heart rhythm problems become a serious risk.
Why Dextrose Is Always Given With It
Insulin’s primary job in everyday physiology is lowering blood sugar, and that effect doesn’t disappear just because you’re using it for potassium. Without supplemental glucose, the insulin dose used for hyperkalemia would cause significant hypoglycemia in most patients. Even with dextrose, low blood sugar remains the most common complication of this treatment.
A 2024 study from a tertiary care emergency department in India found that 44% of patients treated with insulin and dextrose for hyperkalemia developed hypoglycemia within three hours. Ten percent experienced severe hypoglycemia, with blood glucose dropping below 54 mg/dL. Those numbers were higher than most prior studies, but hypoglycemia rates between 10% and 75% have been reported across different hospital settings, making it a consistently recognized problem. Current guidelines recommend hourly blood glucose checks for up to six hours after treatment.
Adjustments for Kidney Disease
Hyperkalemia is especially common in people with chronic kidney disease or end-stage renal disease, since the kidneys are the body’s primary route for eliminating potassium. Insulin works just as well at lowering potassium in these patients. The potassium-shifting effect is not blunted by kidney failure.
The risk of hypoglycemia, however, is significantly higher. Healthy kidneys break down a substantial portion of circulating insulin. When kidney function is severely reduced, insulin stays active in the bloodstream much longer, amplifying its blood sugar-lowering effect. Several factors raise the risk further: not having diabetes (meaning the body’s own insulin production is still intact), already taking blood sugar-lowering medications, and having a lower blood glucose level before treatment starts.
Because of this, many hospitals now use a reduced dose of 5 units instead of 10 for patients with advanced kidney disease. Studies comparing the two doses found no meaningful difference in potassium reduction, suggesting the lower dose is equally effective at shifting potassium while cutting the hypoglycemia risk.
How It Compares to Other Treatments
Insulin with dextrose is considered first-line treatment for acutely lowering serum potassium. A 2025 systematic review and meta-analysis of 101 studies confirmed that insulin combined with glucose, inhaled albuterol (a beta-agonist bronchodilator), intravenous albuterol, or combinations of these reduce potassium by 0.7 to 1.2 mmol/L. The same review found no evidence that sodium bicarbonate lowers potassium levels.
Adding nebulized albuterol to insulin seems like it should produce a larger drop, since albuterol shifts potassium into cells through a different mechanism. In practice, though, a comparative study found that patients who received insulin alone had a potassium reduction of 0.85 mmol/L within four hours, while those who received insulin plus albuterol dropped 0.96 mmol/L. The difference was not statistically significant. Albuterol is still sometimes used as an add-on, particularly when potassium levels are critically high, but insulin remains the backbone of acute treatment.
What Insulin Does Not Do
The most important thing to understand is that insulin is a temporizing measure. It moves potassium from the bloodstream into cells, buying time, but it doesn’t remove a single milliequivalent of potassium from the body. Once the insulin’s effect wears off in 4 to 6 hours, potassium will drift back out of cells and into the blood unless the underlying cause has been addressed.
Actual potassium removal requires other interventions: the kidneys (if functioning), dialysis, or potassium-binding agents taken by mouth that trap potassium in the gut for elimination in stool. Calcium is sometimes given at the same time as insulin, but its role is different. It stabilizes heart cell membranes to protect against dangerous rhythms without affecting potassium levels at all. Insulin handles the potassium number; calcium handles the immediate cardiac risk; and elimination therapies handle the long-term surplus.